Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
7.63
-0.07 (-0.91%)
Nov 17, 2026, 3:04 PM CST

SHE:300009 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
2,3362,6472,5362,8662,3312,169
Revenue Growth
-9.36%4.36%-11.51%22.94%7.48%27.47%
Gross Profit
1,7411,9861,9552,2401,8181,733
Operating Income
698.92800.39759.09912.92755.7599.3
Net Income
651.66735.19706.95847.23703.26206.63
Earnings Per Share
0.390.440.420.510.430.13
EPS Growth
-2.44%4.76%-17.03%17.72%230.77%-40.91%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Dec '21
Biological Products
1,9801,8652,1001,5561,295
Chinese Patent Medicine
289.17298.97358.25404.44518.74
Synthetic drugs
150.25151.13178.58147.47134.65
Active Pharmaceutical Ingredient (API)
101.58103.2491.7772.3562.56
Technical Services
24.7331.6258.3476.3994.64
Others
100.8885.6979.0474.2254.53
Total
2,6472,5362,8662,3312,160

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
1,4301,5831,4441,4561,1671,128
Total Debt
75.6132.9653.9656.6333.1427.04
Net Cash (Debt)
1,3541,5501,3901,3991,1341,101
Net Cash Growth
5.84%11.54%-0.66%23.35%3.03%25.04%
Net Cash Per Share
0.810.930.830.840.690.69

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
665.41863.22685.37952.97698.98592.17
Capital Expenditures
-152.49-126.89-117.22-195.34-474.34-131.23
Free Cash Flow
512.92736.33568.15757.64224.64460.94
Free Cash Flow Growth
-31.47%29.60%-25.01%237.27%-51.27%41.27%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
74.54%75.04%77.08%78.15%77.97%79.89%
Operating Margin
29.92%30.24%29.93%31.86%32.42%27.63%
Pretax Margin
31.48%31.48%31.66%32.10%35.77%13.61%
Profit Margin
27.89%27.78%27.88%29.56%30.17%9.53%
FCF Margin
21.96%27.82%22.40%26.44%9.64%21.25%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Dividend Per Share
0.2500.2500.2500.2500.2500.200
Dividend Per Share Growth
0%0%0%0%25.00%19.98%
Dividend Yield
3.28%2.61%2.91%2.43%2.54%1.53%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
19.5621.7220.3920.1822.21103.80
Forward PE
18.7814.1614.1617.4721.2735.62
P/FCF Ratio
25.0321.6825.3722.5669.5546.53
PS Ratio
5.496.035.685.976.709.89